News Headlines Article

CMS wants to overhaul Part B drug payments. Oncologists call the plan ‘absurd.’
Modern Healthcare

The Obama administration unveiled a five-year Medicare initiative Tuesday that would test new ways of paying for outpatient drugs. The pharmaceutical industry and some provider groups quickly attacked it as an irresponsible experiment. The mandatory program, proposed by the CMS Innovation Center would explore whether alternative models for covering drugs under Medicare Part B would curb costs and reward better patient outcomes.